Kiyatec focuses on advancing drug discovery and personalized medicine through innovative technologies. Kiyatec specializes in 3D cell culture models and predictive analytics to evaluate drug response and treatment outcomes. Their proprietary 3D cell culture technology cultivates patients' live tumor cells in a controlled environment that closely replicates their actual tumor and immune system. Their platform enables the testing of drug candidates on patient-derived cells in a 3D environment, which better mimics the complex conditions found in the human body compared to traditional 2D cell cultures. By leveraging these advanced models and predictive analytics, Kiyatec aims to help identify promising drug candidates more efficiently and enable healthcare providers to tailor treatments to individual patients, ultimately improving patient outcomes in various disease areas such as cancer and other complex disorders.
